KCC009

An inhibitor of TG2

Price Not Available 50 mg KCC009 Supplier Page
Catalog Number 42453
Alternative Name(s) ERW1095B
Research Area Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cell Biology|Cytoskeleton & Motor Proteins||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Neuroscience|Neurodegenerative Disorders|Multiple Sclerosis
Molecular Formula C21H22BrN3O5
CAS# 744198-19-4
Purity ≥98%
Inchi InChI=1S/C21H22BrN3O5/c22-19-11-17(30-25-19)12-23-20(27)18(10-14-6-8-16(26)9-7-14)24-21(28)29-13-15-4-2-1-3-5-15/h1-9,17-18,26H,10-13H2,(H,23,27)(H,24,28)/t17?,18-/m0/s1
Inchi Key MRULUIQNANUWTK-ZVAWYAOSSA-N
SMILES O=C(N[C@@H](CC1=CC=C(O)C=C1)C(NCC2ON=C(Br)C2)=O)OCC3=CC=CC=C3
Size 50 mg
Supplier Page https://www.caymanchem.com/product/42453